Stocksigma LogoStocksigma Logo

Nectar Lifesciences Reports Q2 FY27 Consolidated Net Profit of ₹2.72 Crore

Nectar Lifesciences reported consolidated revenue from continuing operations of ₹1.10 lakh for the quarter ended 30th Sep'26, alongside other income of

Nectar Lifesciences Reports Q2 FY27 Consolidated Net Profit of ₹2.72 Crore

Nectar Lifesciences Ltd · Outcome · 14 Nov 2026, 5:28 pm

Nectar Lifesciences Reports Q2 FY27 Consolidated Net Profit of ₹2.72 Crore Nectar Lifesciences reported consolidated revenue from continuing operations of ₹1.10 lakh for the quarter ended 30th Sep'26, alongside other income of ₹14.06 crore. Consolidated net profit reached ₹2.72 crore versus a net loss of ₹176.01 crore in the restated quarter ended 30th Sep'25, with basic continuing EPS at ₹0.18. The company is pivoting towards real estate, possessing liquid cash and equivalents of ₹115.55 crore as of 30th Sep'26. Additionally, it incurred an investment loss of ₹26.73 crore in H1 FY27 from market volatility.

Original exchange filing (PDF)

More announcements from Nectar Lifesciences Ltd

All Nectar Lifesciences Ltd announcements